CPIX — Cumberland Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $127.21m
- $123.01m
- $44.52m
Brief: Cumberland Pharmaceuticals Reports 14% Revenue Growth
Brief: Cumberland Pharmaceuticals Appoints Martin Brown Jr. To Board
Brief: Cumberland Pharmaceuticals Reports 6% Revenue Growth
Promotion Agreement With Verity Pharmaceuticals To Expand Support For Sancuso®
Brief: Cumberland Pharma Reports Qtrly Revenue Of $8.3 Mln
Brief: Cumberland Pharmaceuticals Acquires Sancuso® From Kyowa Kirin North America
Brief: Cumberland Enters Into Amendment To Expand Capital Available On Bank Line Of Credit To $20 Million
U.S. STOCKS ON THE MOVE-Didi, MEI Pharma, TG Therapeutics, Cumberland Pharma
U.S. STOCKS ON THE MOVE-Apple, Moderna, Stay-at-home stocks, Travel stocks
U.S. STOCKS ON THE MOVE-Facebook, Tesla, Regeneron Pharma, ImmunoGen
U.S. STOCKS ON THE MOVE-Moderna, Twitter, Erytech Pharma, Fennec Pharma
Cumberland Pharma more than doubles on FDA nod for pain reliever
Brief: Caldolor Now FDA Approved For Pre-Operative Administration
Brief: Cumberland Pharmaceuticals Posts Q3 Loss Per Share Of $0.07
Brief: Cumberland Pharmaceuticals Says On Oct 28, Co Entered Fourth Amendment To Revolving Credit Note And Fifth Amendment To Revolving Credit Loan Agreement
Brief: Cumberland Pharmaceuticals Launches RediTrex Product Line For Active Rheumatoid, Juvenile Idiopathic And Severe Psoriatic Arthritis
Cumberland Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Cumberland Pharmaceuticals Posts Q2 EPS Of $0.08
Cumberland Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview